Find Ethyl Loflazepate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Victan, Meilax, 29177-84-2, Ethyl fluclozepate, Cm 6912, Loflazepic acid, ethyl ester
Molecular Formula
C18H14ClFN2O3
Molecular Weight
360.8  g/mol
InChI Key
CUCHJCMWNFEYOM-UHFFFAOYSA-N
FDA UNII
VJB5FW9W9J

Ethyl Loflazepate
1 2D Structure

Ethyl Loflazepate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate
2.1.2 InChI
InChI=1S/C18H14ClFN2O3/c1-2-25-18(24)16-17(23)21-14-8-7-10(19)9-12(14)15(22-16)11-5-3-4-6-13(11)20/h3-9,16H,2H2,1H3,(H,21,23)
2.1.3 InChI Key
CUCHJCMWNFEYOM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCOC(=O)C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F
2.2 Other Identifiers
2.2.1 UNII
VJB5FW9W9J
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cm 6912

2. Ethyl Flucozepate

3. Victan

2.3.2 Depositor-Supplied Synonyms

1. Victan

2. Meilax

3. 29177-84-2

4. Ethyl Fluclozepate

5. Cm 6912

6. Loflazepic Acid, Ethyl Ester

7. Vjb5fw9w9j

8. Ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1h-1,4-benzodiazepine-3-carboxylate

9. 1h-1,4-benzodiazepine-3-carboxylic Acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, Ethyl Ester

10. Ethylis Loflazepas

11. Ethyl Loflazepate [inn:jan]

12. Loflazepate D'ethyle

13. Loflazepato De Etilo

14. Ethylis Loflazepas [inn-latin]

15. Loflazepate D'ethyle [inn-french]

16. Loflazepato De Etilo [inn-spanish]

17. Einecs 249-489-4

18. Unii-vjb5fw9w9j

19. Brn 0765264

20. Dea No. 2758

21. Meilax (tn)

22. Cm-6912

23. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate

24. 5-25-08-00124 (beilstein Handbook Reference)

25. Ethyl Loflazepate (jan/inn)

26. Schembl156702

27. Ethyl Loflazepate [mi]

28. Ethyl Loflazepate [inn]

29. Ethyl Loflazepate [jan]

30. Chembl1213460

31. Chebi:31573

32. Dtxsid60865475

33. Ethyl Loflazepate [mart.]

34. Ethyl Loflazepate [who-dd]

35. Db01545

36. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-1,4-benzodiazepine-3-carboxylate

37. D01293

38. Q5404460

39. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-1,4-benzodiazepine-3-carboxylate #

40. (e)-ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-benzo[e][1,4]diazepine-3-carboxylate

41. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-benzo[e][1,4]diazepine-3-carboxylate

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 360.8 g/mol
Molecular Formula C18H14ClFN2O3
XLogP32.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass360.0676982 g/mol
Monoisotopic Mass360.0676982 g/mol
Topological Polar Surface Area67.8 Ų
Heavy Atom Count25
Formal Charge0
Complexity556
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Anxiety Agents

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)


4.2 ATC Code

N - Nervous system

N05 - Psycholeptics

N05B - Anxiolytics

N05BA - Benzodiazepine derivatives

N05BA18 - Ethyl loflazepate


API SUPPLIERS

read-more
read-more

01

TATEYAMA KASEI CO LTD

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Cosmoprof India
Not Confirmed
arrow

TATEYAMA KASEI CO LTD

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Cosmoprof India
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

02

R L Fine Chem

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Cosmoprof India
Not Confirmed
arrow

03

Ryoto Fine Co

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Cosmoprof India
Not Confirmed
arrow

Ryoto Fine Co

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Cosmoprof India
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

04

ZHEJIANG LANGHUA PHARMACEUTICAL CO...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Cosmoprof India
Not Confirmed
arrow

ZHEJIANG LANGHUA PHARMACEUTICAL CO...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Cosmoprof India
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty